Adjuvant Temozolomide Beyond Six Cycles in Patients With Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Neuro-Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase II Randomized, Multicenter, Open-Label Trial of Continuing Adjuvant Temozolomide Beyond 6 Cycles in Patients With Glioblastoma (GEINO 14-01)
Neuro-oncology 2020 Dec 18;22(12)1851-1861, C Balana, MA Vaz, J Manuel Sepúlveda, C Mesia, S Del Barco, E Pineda, J Muñoz-Langa, A Estival, R de Las Peñas, J Fuster, R Gironés, LM Navarro, M Gil-Gil, M Alonso, A Herrero, S Peralta, C Olier, P Perez-Segura, M Covela, M Martinez-García, A Berrocal, O Gallego, R Luque, FJ Perez-Martín, A Esteve, N Munne, M Domenech, S Villa, C Sanz, C CarratoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.